Clinical trials: Severe Aplastic Anemia

Bone Marrow Transplant (BMT)

HPC Offered for PRESERVE Expansion

• Recruiting
• Age: 12 to 80 years
• Observational study

Ossium recognizes that not all patients who could benefit from Ossium's HPC, Marrow can access the PRESERVE trial for logistical or eligibility reasons.

Trial name

HOPE (NCT07145411)

Testing

Bone Marrow Transplant with Ossium's HPC, Marrow (bone marrow recovered from deceased organ and tissue donors)

Where

5 sites in United States

Volunteers

10 people

Sponsor

Ossium Health, Inc.